Clontech/WST-1细胞增殖分析试剂盒/2500测试/MK400

价格
面议
货号:MK400
浏览量:127
品牌:Clontech
服务
全国联保
正品保证
正规发票
签订合同
商品描述

The Premix WST-1 Cell Proliferation Assay System allows fast and easy colorimetric measurement of cell proliferation and viability in a 96-well format, without radioactive isotopes or organic solvents. The Premix WST-1 Cell Proliferation Assay System is also applicable to cytotoxicity and inhibitory assays, where dye production decreases rather than increases.

The Premix WST-1 Cell Proliferation Assay System allows fast and easy colorimetric measurement of cell proliferation and viability in a 96-well format, without radioactive isotopes or organic solvents. The Premix WST-1 Cell Proliferation Assay System is also applicable to cytotoxicity and inhibitory assays, where dye production decreases rather than increases.

The colorimetric assay is based on the cleavage of the tetrazolium salt WST-1 to a formazan-class dye by mitochondrial succinate-tetrazolium reductase in viable cells. As the cells proliferate, more WST-1 is converted to the formazan product. The quantity of formazan dye is directly related to the number of metabolically active cells, and can be quantified by measuring absorbance at 420–480 nm (Amax 450 nm) in a multiwell plate reader.

An effortless protocol

No washing, harvesting, or solubilization steps are required with the Premix WST-1 Cell Proliferation Assay System. The entire procedure, from cell culture to data analysis, can be carried out with a multiwell plate reader in the same 96-well plate.

Once your cells are cultured, the assay can be completed in approximately 1 hour. Simply add the Premixed WST-1 Cell Proliferation Reagent to the plate, culture your cells for at least 30 min in a humidified atmosphere (up to 4 hr, depending on cell type and density) and measure the absorbance. The colored product is generated continuously, so you can monitor the progress of your experiment over time by repeatedly reading the plate and returning it to the incubator for further development. This eliminates guesswork and ensures that the optimal assay endpoint is not overlooked.

Stable reagents

Unlike traditional WST-1 assay reagents, which can only be stored for three days at 4°C or one month at –20°C, the Premixed WST-1 Cell Proliferation Reagent has been formulated for increased stability: it can be stored for two weeks at 4°C or one year at –20°C. It is supplied as a ready-to-use solution containing WST-1 and an electron-coupling reagent, diluted in sterile phosphate-buffered saline.

Non-radioactive, colorimetric assay

Many cell proliferation assays are based on measurements of radioactively labeled nucleoside uptake during DNA synthesis. The Premixed WST-1 Cell Proliferation Reagent assay is nonradioactive, which enhances convenience and laboratory safety. Furthermore, the Premixed WST-1 Cell Proliferation Reagent is highly water-soluble compared to other tetrazolium salts used in similar assays, which may require surfactants or organic solvents for dissolution.

The Premixed WST-1 Cell Proliferation Reagent will simplify and streamline your cell proliferation assays. The simple, one-solution protocol saves time and is easy to use in a 96-well plate format. Plates can be read and returned to the incubator for further development to simplify time-course experiments.

 More Less
美国Clontech www.clontech.com www.takara.com.cn www.takara-bio.com www.takara.co.jp 2005年7月1日,日本最大的生物工程公司TaKaRa公司据说花费了6千万美元成功此收购计划已经于2005年8月底完成,Clontech已成为TaKaRa全资子公司。美国Clontech是1984年由华人方瑞贤创立的,一度曾经是众多海外华人的骄傲。因为方瑞贤创立的是全美第一家,也是建立了最大的分子生物公司,更重要的是Clontech建立了生物技术中建立基因文库的模式。在Clontech被BD收购时已有四百名员工,包括六十五位博士,拥有五十多个专利,产品已达两千多个,堪称全球数一,数二的基因库,提供全球三十多个国家基因实验室或学术界做研究之用。该公司有曾于预期四,预期五,预期八及预期九年被圣荷西及旧金山商业报纸选为一百个成长速度的私人公司。Clontech公司一直锐意进取,其开发的产品多次获得全美R&D100金奖。产品范围包括基因识别,基因表达,基因功能研究,大家熟悉的Smart Race,Altas DNA矩阵,SSH消减杂交,MTN膜,多色荧光蛋白载体,MatchMaker酵母双杂交系列也在其中。TaKaRa公司于1979年年从生产限制性内切酶起步,首先将PCR技术引入日本市场,并逐渐成为日本生命科学研究领域领先的公司.TaKaRa在2004年财政年度试剂销售达到118亿日元(1十亿美元左右),其中85%的收益来自于日本本土市场,其他有部分来自于中国等亚洲市场。此次收购会给Takara带来以下收益:极大地丰富Takara原来的产品线;迅速扩大TaKaRa在欧美市场的份额,因为Clontech 70%以上的销售是来自于欧美,而Takara 85%的收益来自于日本本土市场。本次收购将全面扩展日本产品在欧美的销售。另外宝将整合并加强日本本土和位于美国的Clontech公司研发部,加快产品的开发,提高宝在全球生命科学研究市场的份额。